Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Journal of the American Academy of Dermatology
|
February 26, 2018
Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis
Benjamin Lockshin, Yevgeniy Balagula, Joseph F Merola
Seminars in Arthritis and Rheumatism
|
April 2, 2017
Switching biologics in the treatment of psoriatic arthritis
Joseph F Merola, Benjamin Lockshin, Elinor A Mody
Journal of Drugs in Dermatology : JDD
|
November 16, 2020
Therapies for Psoriasis: Clinical and Economic Comparisons
Albert Marchetti, Tina Bhutani, Benjamin Lockshin, et al.
Journal of Dermatological Science
|
December 3, 2019
Apremilast mechanism of efficacy in systemic-naive patients with moderate plaque psoriasis: Pharmacodynamic results from the UNVEIL study
Bruce Strober, Ali Alikhan, Benjamin Lockshin, et al.
Acta Dermato-Venereologica
|
February 13, 2024
Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator's Global Assessment: A Post Hoc Analysis of a Phase 3 Trial
Michael J Cork, Benjamin Lockshin, Andreas Pinter, et al.
Dermatology and Therapy
|
February 27, 2022
A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab
Andrew Blauvelt, Russel Burge, Gaia Gallo, et al.
American Journal of Clinical Dermatology
|
October 16, 2019
Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis in the United States: A Multicenter Observational Study
Phillip J Mease, Clive Liu, Evan Siegel, et al.
The Journal of Dermatological Treatment
|
May 5, 2021
Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis
Andrew Blauvelt, Kenneth B Gordon, Patricia Lee, et al.
Journal of Drugs in Dermatology : JDD
|
February 6, 2025
A Review of the Safety and Efficacy of Deucravacitinib for Plaque Psoriasis: An Expert Consensus Panel
Milaan Shah, Joshua Burshtein, Danny Zakria, et al.
Dermatology and Therapy
|
February 10, 2024
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel
Joshua Burshtein, Milaan Shah, Danny Zakria, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Journal of the American Academy of Dermatology
|
February 26, 2018
Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis
Benjamin Lockshin, Yevgeniy Balagula, Joseph F Merola
Seminars in Arthritis and Rheumatism
|
April 2, 2017
Switching biologics in the treatment of psoriatic arthritis
Joseph F Merola, Benjamin Lockshin, Elinor A Mody
Journal of Drugs in Dermatology : JDD
|
November 16, 2020
Therapies for Psoriasis: Clinical and Economic Comparisons
Albert Marchetti, Tina Bhutani, Benjamin Lockshin, et al.
Journal of Dermatological Science
|
December 3, 2019
Apremilast mechanism of efficacy in systemic-naive patients with moderate plaque psoriasis: Pharmacodynamic results from the UNVEIL study
Bruce Strober, Ali Alikhan, Benjamin Lockshin, et al.
Acta Dermato-Venereologica
|
February 13, 2024
Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator's Global Assessment: A Post Hoc Analysis of a Phase 3 Trial
Michael J Cork, Benjamin Lockshin, Andreas Pinter, et al.
Dermatology and Therapy
|
February 27, 2022
A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab
Andrew Blauvelt, Russel Burge, Gaia Gallo, et al.
American Journal of Clinical Dermatology
|
October 16, 2019
Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis in the United States: A Multicenter Observational Study
Phillip J Mease, Clive Liu, Evan Siegel, et al.
The Journal of Dermatological Treatment
|
May 5, 2021
Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis
Andrew Blauvelt, Kenneth B Gordon, Patricia Lee, et al.
Journal of Drugs in Dermatology : JDD
|
February 6, 2025
A Review of the Safety and Efficacy of Deucravacitinib for Plaque Psoriasis: An Expert Consensus Panel
Milaan Shah, Joshua Burshtein, Danny Zakria, et al.
Dermatology and Therapy
|
February 10, 2024
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel
Joshua Burshtein, Milaan Shah, Danny Zakria, et al.
Page
of 3